Iron(II,III) oxide

Iron(II,III) oxide, or black iron oxide, is the chemical compound with formula Fe₃O₄. It occurs in nature as the mineral magnetite. It is one of a number of iron oxides, the others being iron(II) oxide (FeO), which is rare, and iron(III) oxide (Fe₂O₃) which also occurs naturally as the mineral hematite. It contains both Fe²⁺ and Fe³⁺ ions and is sometimes formulated as FeO·Fe₂O₃. This iron oxide is encountered in the laboratory as a black powder. It exhibits permanent magnetism and is ferrimagnetic, but is sometimes incorrectly described as ferromagnetic. Its most extensive use is as a black pigment (see: Mars Black). For this purpose, it is synthesized rather than being extracted from the naturally occurring mineral as the particle size and shape can be varied by the method of production.

Preparation

Heated iron metal interacts with steam to form iron oxide and hydrogen gas.

:<chem>3Fe + 4H2O->Fe3O4 + 4H2 </chem>

Under anaerobic conditions, ferrous hydroxide (Fe(OH)₂) can be oxidized by water to form magnetite and molecular hydrogen. This process is described by the Schikorr reaction:

:<chem>\underset{ferrous\ hydroxide}{3Fe(OH)2} -> \underset{magnetite}{Fe3O4} + \underset{hydrogen}{H2} + \underset{water}{2H2O}</chem>

This works because crystalline magnetite (Fe₃O₄) is thermodynamically more stable than amorphous ferrous hydroxide (Fe(OH)₂ ).

The Massart method of preparation of magnetite as a ferrofluid, is convenient in the laboratory: mix iron(II) chloride and iron(III) chloride in the presence of sodium hydroxide.

A more efficient method of preparing magnetite without troublesome residues of sodium, is to use ammonia to promote chemical co-precipitation from the iron chlorides: first mix solutions of 0.1 M FeCl₃·6H₂O and FeCl₂·4H₂O with vigorous stirring at about 2000 rpm. The molar ratio of the FeCl₃:FeCl₂ should be about 2:1. Heat the mix to 70&nbsp;°C, then raise the speed of stirring to about 7500 rpm and quickly add a solution of NH₄OH (10 volume %). A dark precipitate of nanoparticles of magnetite forms immediately.

In both methods, the precipitation reaction relies on rapid transformation of acidic iron ions into the spinel iron oxide structure at pH 10 or higher.

Controlling the formation of magnetite nanoparticles presents challenges: the reactions and phase transformations necessary for the creation of the magnetite spinel structure are complex. The subject is of practical importance because magnetite particles are of interest in bioscience applications such as magnetic resonance imaging (MRI), in which iron oxide magnetite nanoparticles potentially present a non-toxic alternative to the gadolinium-based contrast agents currently in use. However, difficulties in controlling the formation of the particles, still frustrate the preparation of superparamagnetic magnetite particles, that is to say: magnetite nanoparticles with a coercivity of 0 A/m, meaning that they completely lose their permanent magnetisation in the absence of an external magnetic field. The smallest values currently reported for nanosized magnetite particles is Hc = 8.5 A m⁻¹, whereas the largest reported magnetization value is 87 Am² kg⁻¹ for synthetic magnetite.

Pigment quality Fe₃O₄, so called synthetic magnetite, can be prepared using processes that use industrial wastes, scrap iron or solutions containing iron salts (e.g. those produced as by-products in industrial processes such as the acid vat treatment (pickling) of steel):

• Oxidation of Fe metal in the Laux process where nitrobenzene is treated with iron metal using FeCl₂ as a catalyst to produce aniline:

:3Fe₂O₃ + H₂ → 2Fe₃O₄ +H₂O

Reduction of Fe₂O₃ with CO:

:3Fe₂O₃ + CO → 2Fe₃O₄ + CO₂

Production of nano-particles can be performed chemically by taking for example mixtures of Fe^II and Fe^III salts and mixing them with alkali to precipitate colloidal Fe₃O₄. The reaction conditions are critical to the process and determine the particle size.

Iron(II) carbonate can also be thermally decomposed into Iron(II,III):

:

Reactions

Reduction of magnetite ore by CO in a blast furnace is used to produce iron as part of steel production process:

:<math chem>\ce{\underbrace{2Fe3O4}_{magnetite} + {1/2O2} ->}\ {\color{Brown}\ce{\underbrace{3(\gamma-Fe2O3)}_{maghemite}</math>

More vigorous calcining (roasting in air) gives red pigment quality α-Fe₂O₃ (hematite): There is a distribution of coordination sites in the liquid state, with the majority of both Fe^II and Fe^III being 5-coordinated to oxygen and minority populations of both 4- and 6-fold coordinated iron.

Properties

thumb|240px|Sample of [[magnetite, naturally occurring Fe₃O₄.]]

Fe₃O₄ is ferrimagnetic with a Curie temperature of . There is a phase transition at , called Verwey transition where there is a discontinuity in the structure, conductivity and magnetic properties. This effect has been extensively investigated and whilst various explanations have been proposed, it does not appear to be fully understood.

While it has much higher electrical resistivity than iron metal (96.1 nΩ m), Fe₃O₄'s electrical resistivity (0.3 mΩ m ) is significantly lower than that of Fe₂O₃ (approx kΩ m). This is ascribed to electron exchange between the Fe^II and Fe^III centres in Fe₃O₄. The latter uses an HTS (high temperature shift catalyst) of iron oxide stabilised by chromium oxide.

| legal_EU = Rx-only

| legal_EU_comment =

| legal_UN = <!-- N I, II, III, IV / P I, II, III, IV -->

| legal_UN_comment =

| legal_status = <!-- For countries not listed above -->

<!-- Pharmacokinetic data -->

| bioavailability =

| protein_bound =

| metabolism =

| metabolites =

| onset =

| elimination_half-life =

| duration_of_action =

| excretion =

<!-- Identifiers -->

| CAS_number = 1309-38-2

| CAS_supplemental =

| PubChem =

| IUPHAR_ligand =

| DrugBank = DB06215

| ChemSpiderID =

| UNII = CLH5FT6412

| KEGG = D04177

| ChEBI = 46726

| ChEMBL =

| NIAID_ChemDB =

| PDB_ligand =

| synonyms =

<!-- Chemical and physical data -->

| IUPAC_name = iron(2+);iron(3+);oxygen(2-)

| Fe = 3 | O = 4

| SMILES = [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3]

| StdInChI = 1S/3Fe.4O/q+2;2*+3;4*-2

| StdInChI_comment =

| StdInChIKey = WTFXARWRTYJXII-UHFFFAOYSA-N

| density =

| density_notes =

| melting_point =

| melting_high =

| melting_notes =

| boiling_point =

| boiling_notes =

| solubility =

| sol_units =

| specific_rotation =

Nano particles of Fe₃O₄ are used as contrast agents in MRI scanning.

Ferumoxytol, sold under the brand names Feraheme and Rienso, is an intravenous Fe₃O₄ preparation for treatment of anemia resulting from chronic kidney disease. Ferumoxytol is manufactured and globally distributed by AMAG Pharmaceuticals.

References